Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in […]
(HealthDay)—Nationwide, about half of Medicare fee-for-service beneficiaries with diabetes had eye exams in 2017, according to research published in the […]
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok